COVID-19 Impact on Global Vaccine Conjugate, Market Insights and Forecast to 2026

COVID-19 Impact on Global Vaccine Conjugate, Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Vaccine Conjugate Product Introduction
1.2 Market Segments
1.3 Key Vaccine Conjugate Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Vaccine Conjugate Market Size Growth Rate by Type
1.4.2 Monovalent
1.4.3 Multivalent
1.4.4 Others
1.5 Market by Application
1.5.1 Global Vaccine Conjugate Market Size Growth Rate by Application
1.5.2 Influenza
1.5.3 Meningococcal
1.5.4 Pneumococcal
1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Vaccine Conjugate Industry Impact
1.6.1 How the Covid-19 is Affecting the Vaccine Conjugate Industry
1.6.1.1 Vaccine Conjugate Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Vaccine Conjugate Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Vaccine Conjugate Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Vaccine Conjugate Market Size Estimates and Forecasts
2.1.1 Global Vaccine Conjugate Revenue 2015-2026
2.1.2 Global Vaccine Conjugate Sales 2015-2026
2.2 Vaccine Conjugate Market Size by Region: 2020 Versus 2026
2.2.1 Global Vaccine Conjugate Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Vaccine Conjugate Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Vaccine Conjugate Competitor Landscape by Players
3.1 Vaccine Conjugate Sales by Manufacturers
3.1.1 Vaccine Conjugate Sales by Manufacturers (2015-2020)
3.1.2 Vaccine Conjugate Sales Market Share by Manufacturers (2015-2020)
3.2 Vaccine Conjugate Revenue by Manufacturers
3.2.1 Vaccine Conjugate Revenue by Manufacturers (2015-2020)
3.2.2 Vaccine Conjugate Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Vaccine Conjugate Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Vaccine Conjugate Revenue in 2019
3.2.5 Global Vaccine Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Vaccine Conjugate Price by Manufacturers
3.4 Vaccine Conjugate Manufacturing Base Distribution, Product Types
3.4.1 Vaccine Conjugate Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Vaccine Conjugate Product Type
3.4.3 Date of International Manufacturers Enter into Vaccine Conjugate Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Vaccine Conjugate Market Size by Type (2015-2020)
4.1.1 Global Vaccine Conjugate Sales by Type (2015-2020)
4.1.2 Global Vaccine Conjugate Revenue by Type (2015-2020)
4.1.3 Vaccine Conjugate Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Vaccine Conjugate Market Size Forecast by Type (2021-2026)
4.2.1 Global Vaccine Conjugate Sales Forecast by Type (2021-2026)
4.2.2 Global Vaccine Conjugate Revenue Forecast by Type (2021-2026)
4.2.3 Vaccine Conjugate Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Vaccine Conjugate Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Vaccine Conjugate Market Size by Application (2015-2020)
5.1.1 Global Vaccine Conjugate Sales by Application (2015-2020)
5.1.2 Global Vaccine Conjugate Revenue by Application (2015-2020)
5.1.3 Vaccine Conjugate Price by Application (2015-2020)
5.2 Vaccine Conjugate Market Size Forecast by Application (2021-2026)
5.2.1 Global Vaccine Conjugate Sales Forecast by Application (2021-2026)
5.2.2 Global Vaccine Conjugate Revenue Forecast by Application (2021-2026)
5.2.3 Global Vaccine Conjugate Price Forecast by Application (2021-2026)
6 North America
6.1 North America Vaccine Conjugate by Country
6.1.1 North America Vaccine Conjugate Sales by Country
6.1.2 North America Vaccine Conjugate Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Vaccine Conjugate Market Facts & Figures by Type
6.3 North America Vaccine Conjugate Market Facts & Figures by Application
7 Europe
7.1 Europe Vaccine Conjugate by Country
7.1.1 Europe Vaccine Conjugate Sales by Country
7.1.2 Europe Vaccine Conjugate Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Vaccine Conjugate Market Facts & Figures by Type
7.3 Europe Vaccine Conjugate Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Vaccine Conjugate by Region
8.1.1 Asia Pacific Vaccine Conjugate Sales by Region
8.1.2 Asia Pacific Vaccine Conjugate Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Vaccine Conjugate Market Facts & Figures by Type
8.3 Asia Pacific Vaccine Conjugate Market Facts & Figures by Application
9 Latin America
9.1 Latin America Vaccine Conjugate by Country
9.1.1 Latin America Vaccine Conjugate Sales by Country
9.1.2 Latin America Vaccine Conjugate Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Vaccine Conjugate Market Facts & Figures by Type
9.3 Central & South America Vaccine Conjugate Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Vaccine Conjugate by Country
10.1.1 Middle East and Africa Vaccine Conjugate Sales by Country
10.1.2 Middle East and Africa Vaccine Conjugate Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Vaccine Conjugate Market Facts & Figures by Type
10.3 Middle East and Africa Vaccine Conjugate Market Facts & Figures by Application
11 Company Profiles
11.1 Merck & Co.
11.1.1 Merck & Co. Corporation Information
11.1.2 Merck & Co. Description, Business Overview and Total Revenue
11.1.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck & Co. Vaccine Conjugate Products Offered
11.1.5 Merck & Co. Recent Development
11.2 GlaxoSmithKline plc.
11.2.1 GlaxoSmithKline plc. Corporation Information
11.2.2 GlaxoSmithKline plc. Description, Business Overview and Total Revenue
11.2.3 GlaxoSmithKline plc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline plc. Vaccine Conjugate Products Offered
11.2.5 GlaxoSmithKline plc. Recent Development
11.3 SutroVax
11.3.1 SutroVax Corporation Information
11.3.2 SutroVax Description, Business Overview and Total Revenue
11.3.3 SutroVax Sales, Revenue and Gross Margin (2015-2020)
11.3.4 SutroVax Vaccine Conjugate Products Offered
11.3.5 SutroVax Recent Development
11.4 Fablife.
11.4.1 Fablife. Corporation Information
11.4.2 Fablife. Description, Business Overview and Total Revenue
11.4.3 Fablife. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Fablife. Vaccine Conjugate Products Offered
11.4.5 Fablife. Recent Development
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description, Business Overview and Total Revenue
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Vaccine Conjugate Products Offered
11.5.5 Pfizer Recent Development
11.6 Sinovac Biotech Ltd.
11.6.1 Sinovac Biotech Ltd. Corporation Information
11.6.2 Sinovac Biotech Ltd. Description, Business Overview and Total Revenue
11.6.3 Sinovac Biotech Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sinovac Biotech Ltd. Vaccine Conjugate Products Offered
11.6.5 Sinovac Biotech Ltd. Recent Development
11.7 Sanofi Pasteur SA.
11.7.1 Sanofi Pasteur SA. Corporation Information
11.7.2 Sanofi Pasteur SA. Description, Business Overview and Total Revenue
11.7.3 Sanofi Pasteur SA. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sanofi Pasteur SA. Vaccine Conjugate Products Offered
11.7.5 Sanofi Pasteur SA. Recent Development
11.1 Merck & Co.
11.1.1 Merck & Co. Corporation Information
11.1.2 Merck & Co. Description, Business Overview and Total Revenue
11.1.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck & Co. Vaccine Conjugate Products Offered
11.1.5 Merck & Co. Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Vaccine Conjugate Market Estimates and Projections by Region
12.1.1 Global Vaccine Conjugate Sales Forecast by Regions 2021-2026
12.1.2 Global Vaccine Conjugate Revenue Forecast by Regions 2021-2026
12.2 North America Vaccine Conjugate Market Size Forecast (2021-2026)
12.2.1 North America: Vaccine Conjugate Sales Forecast (2021-2026)
12.2.2 North America: Vaccine Conjugate Revenue Forecast (2021-2026)
12.2.3 North America: Vaccine Conjugate Market Size Forecast by Country (2021-2026)
12.3 Europe Vaccine Conjugate Market Size Forecast (2021-2026)
12.3.1 Europe: Vaccine Conjugate Sales Forecast (2021-2026)
12.3.2 Europe: Vaccine Conjugate Revenue Forecast (2021-2026)
12.3.3 Europe: Vaccine Conjugate Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Vaccine Conjugate Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Vaccine Conjugate Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Vaccine Conjugate Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Vaccine Conjugate Market Size Forecast by Region (2021-2026)
12.5 Latin America Vaccine Conjugate Market Size Forecast (2021-2026)
12.5.1 Latin America: Vaccine Conjugate Sales Forecast (2021-2026)
12.5.2 Latin America: Vaccine Conjugate Revenue Forecast (2021-2026)
12.5.3 Latin America: Vaccine Conjugate Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Vaccine Conjugate Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Vaccine Conjugate Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Vaccine Conjugate Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Vaccine Conjugate Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Vaccine Conjugate Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Vaccine Conjugate Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Vaccine Conjugate Market Segments
Table 2. Ranking of Global Top Vaccine Conjugate Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Vaccine Conjugate Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Monovalent
Table 5. Major Manufacturers of Multivalent
Table 6. Major Manufacturers of Others
Table 7. COVID-19 Impact Global Market: (Four Vaccine Conjugate Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Vaccine Conjugate Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Vaccine Conjugate Players to Combat Covid-19 Impact
Table 12. Global Vaccine Conjugate Market Size Growth Rate by Application 2020-2026 (K MT)
Table 13. Global Vaccine Conjugate Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 14. Global Vaccine Conjugate Sales by Regions 2015-2020 (K MT)
Table 15. Global Vaccine Conjugate Sales Market Share by Regions (2015-2020)
Table 16. Global Vaccine Conjugate Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Vaccine Conjugate Sales by Manufacturers (2015-2020) (K MT)
Table 18. Global Vaccine Conjugate Sales Share by Manufacturers (2015-2020)
Table 19. Global Vaccine Conjugate Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Vaccine Conjugate by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccine Conjugate as of 2019)
Table 21. Vaccine Conjugate Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Vaccine Conjugate Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Vaccine Conjugate Price (2015-2020) (USD/MT)
Table 24. Vaccine Conjugate Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Vaccine Conjugate Product Type
Table 26. Date of International Manufacturers Enter into Vaccine Conjugate Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Vaccine Conjugate Sales by Type (2015-2020) (K MT)
Table 29. Global Vaccine Conjugate Sales Share by Type (2015-2020)
Table 30. Global Vaccine Conjugate Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Vaccine Conjugate Revenue Share by Type (2015-2020)
Table 32. Vaccine Conjugate Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 33. Global Vaccine Conjugate Sales by Application (2015-2020) (K MT)
Table 34. Global Vaccine Conjugate Sales Share by Application (2015-2020)
Table 35. North America Vaccine Conjugate Sales by Country (2015-2020) (K MT)
Table 36. North America Vaccine Conjugate Sales Market Share by Country (2015-2020)
Table 37. North America Vaccine Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Vaccine Conjugate Revenue Market Share by Country (2015-2020)
Table 39. North America Vaccine Conjugate Sales by Type (2015-2020) (K MT)
Table 40. North America Vaccine Conjugate Sales Market Share by Type (2015-2020)
Table 41. North America Vaccine Conjugate Sales by Application (2015-2020) (K MT)
Table 42. North America Vaccine Conjugate Sales Market Share by Application (2015-2020)
Table 43. Europe Vaccine Conjugate Sales by Country (2015-2020) (K MT)
Table 44. Europe Vaccine Conjugate Sales Market Share by Country (2015-2020)
Table 45. Europe Vaccine Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Vaccine Conjugate Revenue Market Share by Country (2015-2020)
Table 47. Europe Vaccine Conjugate Sales by Type (2015-2020) (K MT)
Table 48. Europe Vaccine Conjugate Sales Market Share by Type (2015-2020)
Table 49. Europe Vaccine Conjugate Sales by Application (2015-2020) (K MT)
Table 50. Europe Vaccine Conjugate Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Vaccine Conjugate Sales by Region (2015-2020) (K MT)
Table 52. Asia Pacific Vaccine Conjugate Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Vaccine Conjugate Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Vaccine Conjugate Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Vaccine Conjugate Sales by Type (2015-2020) (K MT)
Table 56. Asia Pacific Vaccine Conjugate Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Vaccine Conjugate Sales by Application (2015-2020) (K MT)
Table 58. Asia Pacific Vaccine Conjugate Sales Market Share by Application (2015-2020)
Table 59. Latin America Vaccine Conjugate Sales by Country (2015-2020) (K MT)
Table 60. Latin America Vaccine Conjugate Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Vaccine Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Vaccine Conjugate Revenue Market Share by Country (2015-2020)
Table 63. Latin America Vaccine Conjugate Sales by Type (2015-2020) (K MT)
Table 64. Latin America Vaccine Conjugate Sales Market Share by Type (2015-2020)
Table 65. Latin America Vaccine Conjugate Sales by Application (2015-2020) (K MT)
Table 66. Latin America Vaccine Conjugate Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Vaccine Conjugate Sales by Country (2015-2020) (K MT)
Table 68. Middle East and Africa Vaccine Conjugate Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Vaccine Conjugate Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Vaccine Conjugate Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Vaccine Conjugate Sales by Type (2015-2020) (K MT)
Table 72. Middle East and Africa Vaccine Conjugate Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Vaccine Conjugate Sales by Application (2015-2020) (K MT)
Table 74. Middle East and Africa Vaccine Conjugate Sales Market Share by Application (2015-2020)
Table 75. Merck & Co. Corporation Information
Table 76. Merck & Co. Description and Major Businesses
Table 77. Merck & Co. Vaccine Conjugate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Merck & Co. Product
Table 79. Merck & Co. Recent Development
Table 80. GlaxoSmithKline plc. Corporation Information
Table 81. GlaxoSmithKline plc. Description and Major Businesses
Table 82. GlaxoSmithKline plc. Vaccine Conjugate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. GlaxoSmithKline plc. Product
Table 84. GlaxoSmithKline plc. Recent Development
Table 85. SutroVax Corporation Information
Table 86. SutroVax Description and Major Businesses
Table 87. SutroVax Vaccine Conjugate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. SutroVax Product
Table 89. SutroVax Recent Development
Table 90. Fablife. Corporation Information
Table 91. Fablife. Description and Major Businesses
Table 92. Fablife. Vaccine Conjugate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Fablife. Product
Table 94. Fablife. Recent Development
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Major Businesses
Table 97. Pfizer Vaccine Conjugate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Pfizer Product
Table 99. Pfizer Recent Development
Table 100. Sinovac Biotech Ltd. Corporation Information
Table 101. Sinovac Biotech Ltd. Description and Major Businesses
Table 102. Sinovac Biotech Ltd. Vaccine Conjugate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Sinovac Biotech Ltd. Product
Table 104. Sinovac Biotech Ltd. Recent Development
Table 105. Sanofi Pasteur SA. Corporation Information
Table 106. Sanofi Pasteur SA. Description and Major Businesses
Table 107. Sanofi Pasteur SA. Vaccine Conjugate Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Sanofi Pasteur SA. Product
Table 109. Sanofi Pasteur SA. Recent Development
Table 110. Global Vaccine Conjugate Sales Forecast by Regions (2021-2026) (K MT)
Table 111. Global Vaccine Conjugate Sales Market Share Forecast by Regions (2021-2026)
Table 112. Global Vaccine Conjugate Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 113. Global Vaccine Conjugate Revenue Market Share Forecast by Regions (2021-2026)
Table 114. North America: Vaccine Conjugate Sales Forecast by Country (2021-2026) (K MT)
Table 115. North America: Vaccine Conjugate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 116. Europe: Vaccine Conjugate Sales Forecast by Country (2021-2026) (K MT)
Table 117. Europe: Vaccine Conjugate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Asia Pacific: Vaccine Conjugate Sales Forecast by Region (2021-2026) (K MT)
Table 119. Asia Pacific: Vaccine Conjugate Revenue Forecast by Region (2021-2026) (US$ Million)
Table 120. Latin America: Vaccine Conjugate Sales Forecast by Country (2021-2026) (K MT)
Table 121. Latin America: Vaccine Conjugate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Middle East and Africa: Vaccine Conjugate Sales Forecast by Country (2021-2026) (K MT)
Table 123. Middle East and Africa: Vaccine Conjugate Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 125. Key Challenges
Table 126. Market Risks
Table 127. Main Points Interviewed from Key Vaccine Conjugate Players
Table 128. Vaccine Conjugate Customers List
Table 129. Vaccine Conjugate Distributors List
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Vaccine Conjugate Product Picture
Figure 2. Global Vaccine Conjugate Sales Market Share by Type in 2020 & 2026
Figure 3. Monovalent Product Picture
Figure 4. Multivalent Product Picture
Figure 5. Others Product Picture
Figure 6. Global Vaccine Conjugate Sales Market Share by Application in 2020 & 2026
Figure 7. Influenza
Figure 8. Meningococcal
Figure 9. Pneumococcal
Figure 10. Others
Figure 11. Vaccine Conjugate Report Years Considered
Figure 12. Global Vaccine Conjugate Market Size 2015-2026 (US$ Million)
Figure 13. Global Vaccine Conjugate Sales 2015-2026 (K MT)
Figure 14. Global Vaccine Conjugate Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Vaccine Conjugate Sales Market Share by Region (2015-2020)
Figure 16. Global Vaccine Conjugate Sales Market Share by Region in 2019
Figure 17. Global Vaccine Conjugate Revenue Market Share by Region (2015-2020)
Figure 18. Global Vaccine Conjugate Revenue Market Share by Region in 2019
Figure 19. Global Vaccine Conjugate Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Vaccine Conjugate Revenue in 2019
Figure 21. Vaccine Conjugate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Vaccine Conjugate Sales Market Share by Type (2015-2020)
Figure 23. Global Vaccine Conjugate Sales Market Share by Type in 2019
Figure 24. Global Vaccine Conjugate Revenue Market Share by Type (2015-2020)
Figure 25. Global Vaccine Conjugate Revenue Market Share by Type in 2019
Figure 26. Global Vaccine Conjugate Market Share by Price Range (2015-2020)
Figure 27. Global Vaccine Conjugate Sales Market Share by Application (2015-2020)
Figure 28. Global Vaccine Conjugate Sales Market Share by Application in 2019
Figure 29. Global Vaccine Conjugate Revenue Market Share by Application (2015-2020)
Figure 30. Global Vaccine Conjugate Revenue Market Share by Application in 2019
Figure 31. North America Vaccine Conjugate Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Vaccine Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Vaccine Conjugate Sales Market Share by Country in 2019
Figure 34. North America Vaccine Conjugate Revenue Market Share by Country in 2019
Figure 35. U.S. Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Vaccine Conjugate Market Share by Type in 2019
Figure 40. North America Vaccine Conjugate Market Share by Application in 2019
Figure 41. Europe Vaccine Conjugate Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Vaccine Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Vaccine Conjugate Sales Market Share by Country in 2019
Figure 44. Europe Vaccine Conjugate Revenue Market Share by Country in 2019
Figure 45. Germany Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Vaccine Conjugate Market Share by Type in 2019
Figure 56. Europe Vaccine Conjugate Market Share by Application in 2019
Figure 57. Asia Pacific Vaccine Conjugate Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Vaccine Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Vaccine Conjugate Sales Market Share by Region in 2019
Figure 60. Asia Pacific Vaccine Conjugate Revenue Market Share by Region in 2019
Figure 61. China Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Vaccine Conjugate Market Share by Type in 2019
Figure 84. Asia Pacific Vaccine Conjugate Market Share by Application in 2019
Figure 85. Latin America Vaccine Conjugate Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Vaccine Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Vaccine Conjugate Sales Market Share by Country in 2019
Figure 88. Latin America Vaccine Conjugate Revenue Market Share by Country in 2019
Figure 89. Mexico Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Vaccine Conjugate Market Share by Type in 2019
Figure 96. Latin America Vaccine Conjugate Market Share by Application in 2019
Figure 97. Middle East and Africa Vaccine Conjugate Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Vaccine Conjugate Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Vaccine Conjugate Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Vaccine Conjugate Revenue Market Share by Country in 2019
Figure 101. Turkey Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Vaccine Conjugate Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Vaccine Conjugate Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Vaccine Conjugate Market Share by Type in 2019
Figure 108. Middle East and Africa Vaccine Conjugate Market Share by Application in 2019
Figure 109. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. GlaxoSmithKline plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. SutroVax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Fablife. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Sinovac Biotech Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Sanofi Pasteur SA. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. North America Vaccine Conjugate Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. North America Vaccine Conjugate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Vaccine Conjugate Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Europe Vaccine Conjugate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Vaccine Conjugate Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 121. Asia Pacific Vaccine Conjugate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Vaccine Conjugate Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 123. Latin America Vaccine Conjugate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Vaccine Conjugate Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 125. Middle East and Africa Vaccine Conjugate Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs